These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 30483249)
1. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection. Holder KA; Lajoie J; Grant MD Front Immunol; 2018; 9():2494. PubMed ID: 30483249 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C Comeau EM; Holder KA; Fudge NJ; Grant MD Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329 [TBL] [Abstract][Full Text] [Related]
3. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts. Newhook N; Fudge N; Grant M Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279 [TBL] [Abstract][Full Text] [Related]
4. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055 [TBL] [Abstract][Full Text] [Related]
5. Late Development of FcεRγ Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M Front Immunol; 2018; 9():1050. PubMed ID: 29868012 [TBL] [Abstract][Full Text] [Related]
6. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026 [TBL] [Abstract][Full Text] [Related]
7. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets. Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220 [TBL] [Abstract][Full Text] [Related]
8. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789 [TBL] [Abstract][Full Text] [Related]
9. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection. Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P Front Immunol; 2018; 9():474. PubMed ID: 29616021 [TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes. Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A Front Immunol; 2019; 10():687. PubMed ID: 31001281 [TBL] [Abstract][Full Text] [Related]
11. Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections. Lee S; Doualeh M; Affandi JS; Makwana N; Irish A; Price P J Med Virol; 2019 Jun; 91(6):1120-1127. PubMed ID: 30636352 [TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. Costa-Garcia M; Vera A; Moraru M; Vilches C; López-Botet M; Muntasell A J Immunol; 2015 Mar; 194(6):2715-24. PubMed ID: 25667418 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients. Bordignon MB; Pesce Viglietti AI; Juliá EP; Sanchez MB; Rölle A; Mandó P; Sabatini L; Ostinelli A; Rizzo MM; Barrio MM; Mordoh J; Fainboim L; Levy EM Cancer Immunol Immunother; 2023 Aug; 72(8):2687-2700. PubMed ID: 37081323 [TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432 [TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus IL-10 augments NK cell cytotoxicity. Holder KA; Grant MD J Leukoc Biol; 2019 Aug; 106(2):447-454. PubMed ID: 30964577 [TBL] [Abstract][Full Text] [Related]
20. Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE Front Immunol; 2019; 10():2403. PubMed ID: 31681293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]